Plasma from patients with DC and hypoalbuminemia induces EC morphological changes, particularly in mitochondria. Albumin mitigates these effects, suggesting a direct modulatory role on mitochondrial function and supporting its therapeutic potential in vascular dysfunction in cirrhosis.
Fischer et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: